Report - A Phase 2b Study of Selinexor in Patients with Relapsed ...€¦ · 4 Selinexor Against Diffuse Aggressive Lymphoma (SADAL):An Open-label, Phase 2b study Patient Population •Patients

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form